It seems we can’t find what you’re looking for. Perhaps searching can help.
Nothing found
Latest Articles
-
Hoth Therapeutics (NASDAQ: HOTH) HT-001 Interim Results First-in-Class Topical Therapy Preserves Cancer Treatment While Resolving Dermatologic Side Effects
June 26, 2025 Comments Off on Hoth Therapeutics (NASDAQ: HOTH) HT-001 Interim Results First-in-Class Topical Therapy Preserves Cancer Treatment While Resolving Dermatologic Side EffectsHoth Therapeutics’ HT-001 Achieves 100% Response Rate in at least one endpoint in Phase 2a Trial in PK Patients for EGFR Inhibitor-Related Skin Toxicities. Hoth Therapeutics will host a Key Opinion Leader (KOL) event on, at 3:30PM EST to [...] -
June 26, 2025 Comments Off on Lottery.com (NASDAQ: LTRY) Announces $10 Million Acquisition of GXR World Sports Assets to Power Global Launch of Sports.com Super App
-
June 25, 2025 Comments Off on Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.
-
June 24, 2025 Comments Off on Lottery.com (NASDAQ: LTRY) Appoints Tim Scoffham as CEO to Lead Global Expansion of Sports.com Media and Lottery.com International
-
June 23, 2025 Comments Off on Lottery.com (NASDAQ: LTRY) Appoints Acclaimed Actor and Director Tamer Hassan as President of Sports.com Studios
Popular Articles
-
Hoth Therapeutics (NASDAQ: HOTH) HT-001 Interim Results First-in-Class Topical Therapy Preserves Cancer Treatment While Resolving Dermatologic Side Effects
June 26, 2025 Comments Off on Hoth Therapeutics (NASDAQ: HOTH) HT-001 Interim Results First-in-Class Topical Therapy Preserves Cancer Treatment While Resolving Dermatologic Side EffectsHoth Therapeutics’ HT-001 Achieves 100% Response Rate in at least one endpoint in Phase 2a Trial in PK Patients for EGFR Inhibitor-Related Skin Toxicities. Hoth Therapeutics will host a Key Opinion Leader (KOL) event on, at 3:30PM EST to [...] -
February 9, 2009 Comments Off on Post 2
-
February 9, 2009 Comments Off on Palm(NASDAQ: PALM) builds momentum;
-
February 9, 2009 Comments Off on Post 4
-
February 10, 2009 Comments Off on Value Investing Opportunities (Prospect List Here)